These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 6419470

  • 1. [Immunohematologic studies on the correlations between (+)-cyanidanol-3-(catergen) therapy and hemolytic anemia].
    Pausch V, Göbel J.
    Wien Med Wochenschr; 1983 Nov 15; 133(21):559-65. PubMed ID: 6419470
    [Abstract] [Full Text] [Related]

  • 2. [Hemolytic autoimmune anemia caused by (+)-cyanidanol-3 (Catergen)].
    Neftel K, Diem P, Gerber H, de Weck AL, Stucki P.
    Schweiz Med Wochenschr; 1980 Mar 08; 110(10):380-2. PubMed ID: 7394468
    [Abstract] [Full Text] [Related]

  • 3. [Autoimmune hemolysis after Catergen ([+]-cyanidanol-3)].
    Neftel K, Fontana A, Guggenheim M, Schenker T, Gmür J, von Felten A, Marti C, Frick PG.
    Schweiz Med Wochenschr; 1987 Nov 14; 117(46):1824-7. PubMed ID: 3423771
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of chronic diseases of the liver with catergen].
    Loginov AS, Dzhalalov KD, Blok IuE, Bendikov EA, Ausheva LKh.
    Ter Arkh; 1986 Nov 14; 58(2):73-6. PubMed ID: 3704945
    [Abstract] [Full Text] [Related]

  • 5. [Catergen-induced immune hemolytic anemia following sensitization by other flavonoids].
    Quadri F, Neftel K, Zwahlen H, Marone C.
    Schweiz Rundsch Med Prax; 1987 Nov 24; 76(48):1338-40. PubMed ID: 3432825
    [No Abstract] [Full Text] [Related]

  • 6. Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
    Pár A, Paál M, Kádas I, Kerekes E, Jávor T.
    Acta Med Hung; 1983 Nov 24; 40(1):17-24. PubMed ID: 6664741
    [Abstract] [Full Text] [Related]

  • 7. [Immune hemolytic anemia caused by catergen].
    Shinkov D, Urumov I, Doĭchinova N, Manolova V, Ananieva R.
    Vutr Boles; 1989 Nov 24; 28(5):84-7. PubMed ID: 2618015
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of hepatic drug metabolism by (+)-cyanidanol-3 (Catergen) in chronic alcoholic liver disease.
    Pár A, Horváth T, Beró T, Kádas I, Pakodi F, Jávor T.
    Acta Physiol Hung; 1984 Nov 24; 64(3-4):449-54. PubMed ID: 6152369
    [Abstract] [Full Text] [Related]

  • 9. [Several years observation of a Catergen (cyanidanol-3) induced immunohemolysis].
    Stühlinger W, Berek K, Grösswang F, Schauer N.
    Schweiz Med Wochenschr; 1990 Mar 10; 120(10):345-8. PubMed ID: 2315653
    [Abstract] [Full Text] [Related]

  • 10. Clinical, enzymological and histological changes in chronic diffuse liver diseases following (+)-cyanidanol-3 (Catergen) treatment.
    Halmy L, Dávid K, Nagy I, Stotz G, Kelemen JT.
    Acta Physiol Hung; 1984 Mar 10; 64(3-4):461-70. PubMed ID: 6152370
    [Abstract] [Full Text] [Related]

  • 11. [Enzymologic evaluation of the effectiveness of the hepatotropic drug catergen in chronic liver diseases].
    Tamarkina AD, Neverov IV, Turitsyna IG, Dement'eva ES, Krylova NI.
    Sov Med; 1985 Mar 10; (12):26-30. PubMed ID: 4095626
    [No Abstract] [Full Text] [Related]

  • 12. Effect of Catergen [(+)cyanidanol-3] on some haemostatic parameters in chronic liver diseases.
    Pfliegler G, Boda Z, Dalmi L, Weisz G, Misz M, Beck P.
    Ther Hung; 1984 Mar 10; 32(1):19-25. PubMed ID: 6571189
    [No Abstract] [Full Text] [Related]

  • 13. [Hemolytic anemia secondary to taking cyanidanol: demonstration of the mechanism of the erythrocyte damage].
    Beris P, Beyner F, Bisetti A, Zubler R, Miescher PA.
    Schweiz Med Wochenschr; 1986 Dec 13; 116(50):1763-6. PubMed ID: 3798066
    [Abstract] [Full Text] [Related]

  • 14. Immune-mediated acute intravascular hemolysis caused by cianidanol (catergen).
    Rotoli B, Giglio F, Bile M, Formisano S.
    Haematologica; 1985 Dec 13; 70(6):495-9. PubMed ID: 3938427
    [No Abstract] [Full Text] [Related]

  • 15. In vitro and in vivo demonstration of the cytoprotective effect of (+)-cyanidanol-3.
    Altorjay I, Dalmi L, Sári B.
    Acta Physiol Hung; 1984 Dec 13; 64(3-4):471-4. PubMed ID: 6532130
    [Abstract] [Full Text] [Related]

  • 16. Effect of cyanidanol-3 on lysosomal enzyme activity of serum and granulocytes in chronic liver disease and active hepatitis.
    Fehér J, Toncsev H, Sréter L, Cornides A, Kiss A.
    Int J Tissue React; 1984 Dec 13; 6(1):75-80. PubMed ID: 6715121
    [Abstract] [Full Text] [Related]

  • 17. [Effect of catergen on the course of acute viral hepatitis].
    Babiuch L, Poznańska H, Rychalska B.
    Przegl Epidemiol; 1981 Dec 13; 35(4):471-7. PubMed ID: 6803308
    [No Abstract] [Full Text] [Related]

  • 18. [A contribution as to the effect of (+)-Cyanidanol-3 in chronic liver disease (author's transl)].
    Sondern W, Leube G.
    Med Klin; 1978 Oct 13; 73(41):1432-6. PubMed ID: 703670
    [Abstract] [Full Text] [Related]

  • 19. [Evaluation of therapeutic effect of catergen in viral hepatitis].
    Boroń P, Boroń-Kaczmarska A, Sokolewicz-Bobrowska E, Szpakowicz T, Nadowska K.
    Pol Tyg Lek; 1979 Aug 13; 34(33):1315-7. PubMed ID: 117435
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic effect of (+)-cyanidanol-3 in toxic alcoholic liver disease and in chronic active hepatitis.
    Abonyi M, Kisfaludy S, Szalay F.
    Acta Physiol Hung; 1984 Aug 13; 64(3-4):455-60. PubMed ID: 6397971
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.